Big Data & Bioengineering

101219312 - Pan-European Breast Image Platform for Advanced AI-based Breast Cancer Screening (BreastScan)

FMS and the Institute of Public Health and Labour of Navarra (ISPLN) are participating in this project co-funded by the EU4Health programme.

The aim of BreastScan is to create a large-scale, high-quality dataset on breast cancer screening that will enable innovative artificial intelligence (AI) tools to be tested to improve breast cancer diagnosis and care, facilitating the contribution to the Cancer Image Europe platform deployed by the EUCAIM project in line with the European Cancer Imaging Initiative.

BreastSCan is co-funded under the EU4Health Programme 2021–2027 under grant agreement no. 101219312. Funded by the European Union. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.

101226717 - Strategies for Healing Implant-associated infections and Enhancing Longevity in Devices (SHIELD)

Within the European MSCA DN programme, SHIELD's objective is to train 16 young researchers by combining basic research with preclinical and clinical research, in collaboration with 27 institutions from 11 countries. SHIELD is structured around three scientific pillars to advance control strategies for infections associated with implants in orthopaedics, otology and dentistry: regenerative medicine, materials science and translational research models. 

The Resist-SMD project (PC24-RESIST-SMD-015-003-007) is funded by the SINAI Agents Grants for collaborative R&D projects (2024 call). It falls under the thematic priority "Personalized Medicine" identified in Navarra’s Smart Specialization Strategy (S4).

Navarrabiomed is a partner of the european project of the European Digital Hub of Navarra, IRIS. The European Digital Hub of Navarra, within the framework of the Digital Europe Programme, has been selected by the European Commission to take part in the first European Digital Innovation Hubs (EDIHs) network. 

This incorporation allows IRIS to act as a catalyst for digital transformation by offering its specialized services in Artificial Intelligence, Supercomputing and Personalised Precision Medicine to companies and public entities at regional, national and European level. 

IRIS Consortium is directed by Goverment of Navarra, with the participation of the most relevant actors in the region´s innovation ecosystem, including entities of the Navarra R+D+I system, SINAI, such as universities, technology and research centres, ICT suppliers, professional associations and sectorial business associations and clusters.

Specifically, IRIS EDIH is made up of 23 entities (two of them as affiliated entities), as providers of advanced digitalisation services of a unique and complementary nature to existing commercial ones, fully aligned with the European Digital Programme, the Navarra Digital 2030 strategy, Personalise Navarra strategy and the S4 regional specialisation strategy. These entities are:ADItech (as cordinating entity), NAITEC, AIN, CNTA, Lurederra, CSIC, UPNA, University of Navarra, ATANA, Nasertic, Navarrabiomed, INTIA, CEIN, Dinabide, Tracasa Instrumental, Tracasa global, Nagrifood, CEN, Chamber of Navarra, Cluster Functional Print, Citi Navarra, Econet and the Official College of Engineers of Navarra. In addition to the Government of Navarra and SODENA, which are associated with the project.

More info through irisnavarra.com

                                          PROMOVIDO POR                COORDINADO POR

The IMPaCT Data Science Program (reference IMP/00019) is one of three funded under the Infrastructure for Precision Medicine associated with Science and Technology (IMPaCT), part of the 2017–2020 Strategic Action in Health of the ISCIII. The program is funded with €4.55 million and coordinated by the Barcelona Supercomputing Center–National Supercomputing Center (BSC). The other IMPaCT programs include the Predictive Medicine Program, coordinated by CIBERESP with €14 million, and the Genomic Medicine Program, also coordinated by CIBERESP with €7.25 million in funding.

FUNDING ORGANISATION: